Literature DB >> 16047089

Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.

Allyn McConkie-Rosell1, Brenda Finucane, Amy Cronister, Liane Abrams, Robin L Bennett, Barbara J Pettersen.   

Abstract

These recommendations describe the minimum standard criteria for genetic counseling and testing of individuals and families with fragile X syndrome, as well as carriers and potential carriers of a fragile X mutation. The original guidelines (published in 2000) have been revised, replacing a stratified pre- and full mutation model of fragile X syndrome with one based on a continuum of gene effects across the full spectrum of FMR1 CGG trinucleotide repeat expansion. This document reviews the molecular genetics of fragile X syndrome, clinical phenotype (including the spectrum of premature ovarian failure and fragile X-associated tremor-ataxia syndrome), indications for genetic testing and interpretation of results, risks of transmission, family planning options, psychosocial issues, and references for professional and patient resources. These recommendations are the opinions of a multicenter working group of genetic counselors with expertise in fragile X syndrome genetic counseling, and they are based on clinical experience, review of pertinent English language articles, and reports of expert committees. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. The professional judgment of a health care provider, familiar with the facts and circumstances of a specific case, will always supersede these recommendations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047089     DOI: 10.1007/s10897-005-4802-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  127 in total

1.  Experience with multiple approaches to the prenatal diagnosis of the fragile X syndrome: amniotic fluid, chorionic villi, fetal blood and molecular methods.

Authors:  L R Shapiro; P L Wilmot; P D Murphy; W R Breg
Journal:  Am J Med Genet       Date:  1988 May-Jun

2.  Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range.

Authors:  Amy K Sullivan; Dana C Crawford; Elizabeth H Scott; Mary L Leslie; Stephanie L Sherman
Journal:  Am J Hum Genet       Date:  2002-05-03       Impact factor: 11.025

3.  Longitudinal study of the carrier testing process for fragile X syndrome: perceptions and coping.

Authors:  A McConkie-Rosell; G A Spiridigliozzi; J A Sullivan; D V Dawson; A M Lachiewicz
Journal:  Am J Med Genet       Date:  2001-01-01

4.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

5.  Paternal transmission of fragile X syndrome.

Authors:  Susan Zeesman; Lonnie Zwaigenbaum; Donald T Whelan; Randi J Hagerman; Flora Tassone; Sherryl A M Taylor
Journal:  Am J Med Genet A       Date:  2004-08-30       Impact factor: 2.802

Review 6.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

7.  The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm.

Authors:  E Reyniers; L Vits; K De Boulle; B Van Roy; D Van Velzen; E de Graaff; A J Verkerk; H Z Jorens; J K Darby; B Oostra
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

Review 8.  Newborn screening for fragile X syndrome.

Authors:  Donald B Bailey
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

9.  Screening for fragile X syndrome: results from a school for mentally retarded children.

Authors:  S Hećimović; I Petek Tarnik; I Barić; Z Cakarun; K Pavelić
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

10.  Population dynamics of a meiotic/mitotic expansion model for the fragile X syndrome.

Authors:  A E Ashley; S L Sherman
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

View more
  33 in total

1.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

2.  Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making.

Authors:  Alison D Archibald; Belinda J McClaren
Journal:  J Community Genet       Date:  2011-11-17

3.  Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.

Authors:  Lisa M Pastore; Logan B Karns; Karen Ventura; Myra L Clark; Richard H Steeves; Nancy Callanan
Journal:  J Genet Couns       Date:  2013-06-14       Impact factor: 2.537

4.  Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency.

Authors:  Deepika Delsa Dean; Sarita Agarwal; Deepa Kapoor; Kuldeep Singh; Chandra Vati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

5.  Newborn screening and cascade testing for FMR1 mutations.

Authors:  Page L Sorensen; Louise W Gane; Mark Yarborough; Randi J Hagerman; Flora Tassone
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

6.  Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers.

Authors:  M A Spath; T B Feuth; E G Allen; A P T Smits; H G Yntema; A Geurts van Kessel; D D M Braat; S L Sherman; C M G Thomas
Journal:  Hum Reprod       Date:  2011-05-15       Impact factor: 6.918

Review 7.  The Genetic Counselor's Role in Managing Ethical Dilemmas Arising in the Laboratory Setting.

Authors:  Jessica R Balcom; Katrina E Kotzer; Lindsey A Waltman; Jennifer L Kemppainen; Brittany C Thomas
Journal:  J Genet Couns       Date:  2016-04-22       Impact factor: 2.537

8.  Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease.

Authors:  Andreea L Seritan; Danh V Nguyen; Sarah Tomaszewski Farias; Ladson Hinton; Jim Grigsby; James A Bourgeois; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

9.  Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.

Authors:  Alice G Ames; Alice Jaques; Obioha C Ukoumunne; Alison D Archibald; Rony E Duncan; Jon Emery; Sylvia A Metcalfe
Journal:  Health Expect       Date:  2012-10-15       Impact factor: 3.377

10.  Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.

Authors:  Allyn McConkie-Rosell; Liane Abrams; Brenda Finucane; Amy Cronister; Louise W Gane; Sarah M Coffey; Stephanie Sherman; Lawrence M Nelson; Elizabeth Berry-Kravis; David Hessl; Sufen Chiu; Natalie Street; Ajay Vatave; Randi J Hagerman
Journal:  J Genet Couns       Date:  2007-05-12       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.